Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A nurse-led sexual rehabilitation intervention after radiotherapy for gynecological cancer.
Bakker RM, Mens JW, de Groot HE, Tuijnman-Raasveld CC, Braat C, Hompus WC, Poelman JG, Laman MS, Velema LA, de Kroon CD, van Doorn HC, Creutzberg CL, Ter Kuile MM. Bakker RM, et al. Among authors: van doorn hc. Support Care Cancer. 2017 Mar;25(3):729-737. doi: 10.1007/s00520-016-3453-2. Epub 2016 Oct 27. Support Care Cancer. 2017. PMID: 27787681 Free PMC article.
Radiation therapy combined with hyperthermia versus cisplatin for locally advanced cervical cancer: Results of the randomized RADCHOC trial.
Lutgens LC, Koper PC, Jobsen JJ, van der Steen-Banasik EM, Creutzberg CL, van den Berg HA, Ottevanger PB, van Rhoon GC, van Doorn HC, Houben R, van der Zee J. Lutgens LC, et al. Among authors: van der zee j, van doorn hc, van rhoon gc, van den berg ha, van der steen banasik em. Radiother Oncol. 2016 Sep;120(3):378-382. doi: 10.1016/j.radonc.2016.02.010. Epub 2016 Feb 17. Radiother Oncol. 2016. PMID: 26897513 Clinical Trial.
The Effect of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in 400 Locally Advanced Cervical Carcinoma Patients.
Kroesen M, Mulder HT, van Holthe JML, Aangeenbrug AA, Mens JWM, van Doorn HC, Paulides MM, Oomen-de Hoop E, Vernhout RM, Lutgens LC, van Rhoon GC, Franckena M. Kroesen M, et al. Among authors: van holthe jml, van doorn hc, van rhoon gc. Front Oncol. 2019 Mar 8;9:134. doi: 10.3389/fonc.2019.00134. eCollection 2019. Front Oncol. 2019. PMID: 30906734 Free PMC article.
Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
Kortekaas KE, Bastiaannet E, van Doorn HC, de Vos van Steenwijk PJ, Ewing-Graham PC, Creutzberg CL, Akdeniz K, Nooij LS, van der Burg SH, Bosse T, van Poelgeest MIE. Kortekaas KE, et al. Among authors: van poelgeest mie, van doorn hc, van der burg sh. Gynecol Oncol. 2020 Dec;159(3):649-656. doi: 10.1016/j.ygyno.2020.09.024. Epub 2020 Sep 21. Gynecol Oncol. 2020. PMID: 32972785 Free article.
Near-infrared fluorescence imaging compared to standard sentinel lymph node detection with blue dye in patients with vulvar cancer - a randomized controlled trial.
Deken MM, van Doorn HC, Verver D, Boogerd LSF, de Valk KS, Rietbergen DDD, van Poelgeest MIE, de Kroon CD, Beltman JJ, van Leeuwen FWB, Putter H, Braak JPBM, de Geus-Oei LF, van de Velde CJH, Burggraaf J, Vahrmeijer AL, Gaarenstroom KN. Deken MM, et al. Among authors: van leeuwen fwb, van poelgeest mie, van doorn hc, van de velde cjh. Gynecol Oncol. 2020 Dec;159(3):672-680. doi: 10.1016/j.ygyno.2020.09.044. Epub 2020 Oct 8. Gynecol Oncol. 2020. PMID: 33041071 Free article. Clinical Trial.
PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System.
Corbeau A, Nout RA, Mens JWM, Horeweg N, Godart J, Kerkhof EM, Kuipers SC, van Poelgeest MIE, Kroep JR, Boere IA, van Doorn HC, Hoogeman MS, van der Heide UA, Putter H, Welters MJP, van der Burg SH, Creutzberg CL, de Boer SM. Corbeau A, et al. Among authors: van der heide ua, van poelgeest mie, van doorn hc, van der burg sh. Cancers (Basel). 2021 Oct 15;13(20):5179. doi: 10.3390/cancers13205179. Cancers (Basel). 2021. PMID: 34680328 Free PMC article.
Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factors.
van Bommel MHD, Steenbeek MP, IntHout J, Hermens RPMG, Hoogerbrugge N, Harmsen MG, van Doorn HC, Mourits MJE, van Beurden M, Zweemer RP, Gaarenstroom KN, Slangen BFM, Brood-van Zanten MMA, Vos MC, Piek JM, van Lonkhuijzen LRCW, Apperloo MJA, Coppus SFPJ, Prins JB, Custers JAE, de Hullu JA. van Bommel MHD, et al. Among authors: van lonkhuijzen lrcw, van doorn hc, van beurden m. Support Care Cancer. 2022 Apr;30(4):3409-3418. doi: 10.1007/s00520-021-06726-4. Epub 2022 Jan 8. Support Care Cancer. 2022. PMID: 34997316 Free PMC article. Clinical Trial.
Efficacy of a nurse-led sexual rehabilitation intervention for women with gynaecological cancers receiving radiotherapy: results of a randomised trial.
Suvaal I, Hummel SB, Mens JM, Tuijnman-Raasveld CC, Tsonaka R, Velema LA, Westerveld H, Cnossen JS, Snyers A, Jürgenliemk-Schulz IM, Lutgens LCHW, Beukema JC, Haverkort MAD, Nowee ME, Nout RA, de Kroon CD, van den Hout WB, Creutzberg CL, van Doorn HC, Ter Kuile MM. Suvaal I, et al. Among authors: van doorn hc. Br J Cancer. 2024 Sep;131(5):808-819. doi: 10.1038/s41416-024-02775-8. Epub 2024 Jul 3. Br J Cancer. 2024. PMID: 38961193 Free PMC article. Clinical Trial.
Cost-effectiveness of a nurse-led sexual rehabilitation intervention for women treated with radiotherapy for gynaecological cancer in a randomized trial.
Suvaal I, van den Hout WB, Hummel SB, Mens JM, Tuijnman-Raasveld CC, Velema LA, Westerveld H, Cnossen JS, Snyers A, Jürgenliemk-Schulz IM, Lutgens LCHW, Beukema JC, Haverkort MAD, Nowee ME, Nout RA, de Kroon CD, van Doorn HC, Creutzberg CL, Ter Kuile MM. Suvaal I, et al. Among authors: van doorn hc. Radiother Oncol. 2024 Dec 14;203:110683. doi: 10.1016/j.radonc.2024.110683. Online ahead of print. Radiother Oncol. 2024. PMID: 39675572 Free article.
121 results